Valeritas to Present at the Rodman & Renshaw Global Investment Conference

BRIDGEWATER, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that John Timberlake, President and Chief Executive Officer is scheduled to present at the Rodman & Renshaw 18th Annual Global Investment Conference.

Event:Rodman & Renshaw 18th Annual Global Investment Conference
Format:Presentation and One-on-One Meetings
Date:Tuesday, September 13, 2016
Time:4:40pm EDT
Location: New York, NY

Audio webcasts of the Company’s presentation will be available by visiting the investor relations section of the Valeritas website at Replays of the presentation will be available for 90 days.

Investors who are not attending the conference but would like to schedule a one-on-one meeting with Valeritas management may do so by contacting Joseph Green at The Ruth Group at

About Valeritas, Inc.
Valeritas is a commercial-stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type 2 diabetes. Valeritas' flagship product, V-Go® Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for patients with Type 2 diabetes that enables patients to administer a continuous preset basal rate of insulin over 24 hours. It also provides on-demand bolus dosing at mealtimes. It is the only basal-bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type 2 diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R&D functions in a state-of-the-art facility in Shrewsbury, Massachusetts. For more information, please visit

Investor Contact: Nick Laudico / Zack Kubow The Ruth Group (646)536-7030 / 7020 Media Contact: Christopher Hippolyte The Ruth Group (646)536-7023

Source:Valeritas, Inc.